Key Documents
Terence Ketter
Academic Appointments
Contact Information
-
Clinical Offices
Psychiatry Department 401 Quarry Rd MC 5723 Stanford, CA 94305-5723 Tel Work (650) 723-8335 Fax (650) 723-2507
- Academic Offices
Personal Information Email Tel (650) 723-2515Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Psychiatry
Administrative Appointments
- Chief, Bipolar Disorders Clinic (1995 - 2004)
Honors and Awards
- Distinguished Fellow, American Psychiatric Association (2006)
- Independent Investigator Award, National Alliance for Research in Schizophrenia and Depression (2003-2005)
- Outstanding Faculty Physician Award, Vaden Health Center, Stanford University (2002)
- Independent Investigator Award, National Alliance for Research in Schizophrenia and Depression (1999-2001)
- Independent Investigator Award, Stanley Foundation Research Award Program (1996-2000)
Professional Education
| Fellowship: | National Institute of Health, MD (1995) |
| Board Certification: | Psychiatry, American Board of Psychiatry and Neurology (1989) |
| Residency: | UCSF Medical Center, CA (1988) |
| Internship: | UCSF Medical Center, CA (1985) |
| Medical Education: | University of Toronto, Canada (1984) |
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Web Site Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | AstraZenica , Bristol-Myers Squibb , Eli Lilly and Company , Pfizer |
Scientific Focus
Current Research Interests
Dr. Ketter has done extensive research into the etiology, phenomenology, and treatment of bipolar disorder. His etiologic research has focused on the use of brain imaging methods such as magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and positron emission tomography (PET) to better understand the neurobiology of mood disorders and to explore the possibility of using these techniques to more effectively target treatments for patients with bipolar disorder. His phenomenologic research has focused on the development and course of bipolar disorder in late adolescence and young adulthood, particularly in college students, and links between creativity, temperament, and mood disorders. His research into treatment has involved clinical trials of novel medications and combinations of medications in the treatment of bipolar disorder, with an emphasis on the use of anticonvulsants.
Clinical Trials
- Short Term Rescue Study of Olanzapine Recruiting
Publications
- Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission. J Psychiatr Res. 2010; (1): 8-14
- Toward interaction of affective and cognitive contributors to creativity in bipolar disorders: A controlled study. J Affect Disord. 2010
- Divalproex extended-release in acute bipolar II depression. J Affect Disord. 2009
- Treating bipolar disorder: monotherapy versus combination therapy. J Clin Psychiatry. 2009; (2): e42
- Resting prefrontal hypometabolism and paralimbic hypermetabolism related to verbal recall deficits in euthymic older adults with bipolar disorder. Am J Geriatr Psychiatry. 2009; (12): 1022-9
Help